These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3193963)

  • 1. Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
    Maloteaux JM; Laterre EC; Laduron PM; Javoy-Agid F; Agid Y
    Mov Disord; 1988; 3(3):255-62. PubMed ID: 3193963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Tong J; Fitzmaurice PS; Ang LC; Furukawa Y; Guttman M; Kish SJ
    Ann Neurol; 2004 Jan; 55(1):125-9. PubMed ID: 14705122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy].
    Kondo S; Tanaka M; Sun X; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1994 Jun; 34(6):531-7. PubMed ID: 7955710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic dysfunction in patients with progressive supranuclear palsy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Oct; 23(14):2083-9. PubMed ID: 18792126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
    Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
    Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
    Villares J; Faucheux B; Herrero MT; Obeso JA; Duyckaerts C; Hauw JJ; Agid Y; Hirsch EC
    Exp Neurol; 1998 Nov; 154(1):146-56. PubMed ID: 9875276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
    Cheng AV; Ferrier IN; Morris CM; Jabeen S; Sahgal A; McKeith IG; Edwardson JA; Perry RH; Perry EK
    J Neurol Sci; 1991 Nov; 106(1):50-5. PubMed ID: 1779239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autonomic nervous function in progressive supranuclear palsy--comparison with Parkinson's disease and healthy controls].
    Sasaki I; Takeuchi H; Deguchi K; Yamada A; Nishioka M; Sakamoto H
    Rinsho Shinkeigaku; 1994 Oct; 34(10):975-9. PubMed ID: 7834957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy].
    Ichihara N; Ichihara SI; Fujii S; Touge T; Nishioka M
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1076-82. PubMed ID: 11332186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the vesicourethral function between progressive supranuclear palsy and Parkinson's disease].
    Wakatsuki A; Tsujihata M; Miyake O; Ito H; Itatani H; Udaka F
    Hinyokika Kiyo; 1993 Jun; 39(6):523-8. PubMed ID: 8337978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
    Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
    Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.